Journal of Clinical Epidemiology
Volume 55, Issue 6 , Pages 619-626 , June 2002

Standardized retrieval of side effects data for meta-analysis of safety outcomes: A feasibility study in acute sinusitis

  • John P.A Ioannidis

      Affiliations

    • Clinical Trials and Evidence-Based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece
    • Division of Clinical Care Research, New England Medical Center, Department of Medicine, Tufts University School of Medicine, 750 Washington Street, Box 63, Boston, MA 02111, USA
    • ,
  • Priscilla Chew

      Affiliations

    • Division of Clinical Care Research, New England Medical Center, Department of Medicine, Tufts University School of Medicine, 750 Washington Street, Box 63, Boston, MA 02111, USA
    • ,
  • Joseph Lau

      Affiliations

    • Division of Clinical Care Research, New England Medical Center, Department of Medicine, Tufts University School of Medicine, 750 Washington Street, Box 63, Boston, MA 02111, USA
    • Corresponding Author InformationCorresponding author. Tel.: 617- 636-7670; fax: 617-636-8023.(J. Lau)

Received 7 July 2001 ,Revised 19 October 2001 ,Accepted 3 December 2001.

References 

  1. Glasziou P, Irwig LM. An evidence-based approach to individualizing treatment. BMJ. 1995;311:1356–1359
  2. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637–639
  3. Bero L, Rennie D. The Cochrane Collaboration. JAMA. 1995;274:1935–1938
  4. Ioannidis JPA, Contopoulos-Ioannidis DG. Reporting of safety data from randomised trials. Lancet. 1998;352:1752–1753
  5. Ioannidis JPA, Lau J. Completeness of safety reporting in randomized trials (an evaluation of 7 medical areas). JAMA. 2001;285:437–443
  6. de Ferranti SD, Ioannidis JP, Lau J, Anninger W, Barza M. Are amoxicillin and folate inhibitors as effective as other antibiotics for acute sinusitis?. BMJ. 1998;317:632–637
  7. Diagnosis and Treatment of Acute Bacterial Sinusitis. Evidence Report/Technology Assessment No. 17 (prepared by New England Medical Center under Contract No. 290-97-0019). AHCPR Publication No. 99-E0017. Rockville, MD: Agency for Health Care Policy and Research; December 1998.
  8. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–748
  9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  10. Simes RJ. Publication bias (the case for an international registry of clinical trials). J Clin Oncol. 1986;4:1529–1541
  11. McCray AT, Ide NC. Design and implementation of a national clinical trials registry. J Am Med Inform Assoc. 2000;7:313–323
  12. Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995;14:2057–2079
  13. Milton J, Logan S, Gilbert R. Well-known signatory does not affect response to a request for information from authors of clinical trials: a randomized controlled trial. In: Program and abstracts of the 9th international Cochrane Colloquium, Lyon; October 2001, abstract O-050.
  14. Mehta SR, Eikelboom JW, Yusuf S. Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy (a meta-analysis). Lancet. 2000;356:449–454
  15. Schoenfeld P. Gastrointestinal safety profile of meloxicam (a meta-analysis and systematic review of randomised controlled trials). Am J Med. 1999;107:48S–54S
  16. Shah MB, Martin JE, Schroeder TJ, First MR. The evaluation of the safety and tolerability of two formulations of cyclosporine (neural and sandimmune. A meta-analysis). Transplantation. 1999;67:1411–1417
  17. Stason WB, Schmid CH, Niedzwiecki D, et al.  Safety of nifedipine in angina pectoris (a meta-analysis). Hypertension. 1999;33:24–31
  18. Chalmers TC, Berrier J, Hewitt P, Berlin J, Reitman D, Nagalingam R, et al. Meta-analysis of randomized controlled trials as a method of estimating rare complications of non-steroidal anti-inflammatory drug therapy. Aliment Pharmacol Ther. 1988;2(Suppl 1):9–26
  19. Li wan Po A, Herxheimer A, Poolsup N, Aziz Z. How do Cochrane reviewers address adverse effects of drug therapy? In: Abstracts of the 8th International Cochrane Colloquium, Capetown; Oct. 25–29, 2000.
  20. Moher D, Schulz KF, Altman DG. The CONSORT statement (revised recommendations for improving the quality of reports of parallel group randomized trials). BMC Med Res Methodol. 2001;1(1):1
  21. Moher D, Schulz KF, Altman DG, Lepage L. The CONSORT statement (revised recommendations for improving the quality of reports of parallel-group randomised trials). Lancet. 2001;357:1191–1194
  22. Stalman W, van Essen GA, van der Graaf Y, De Melker RA. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomised doxycycline trial. Br J Gen Pract. 1997;47:794–799
  23. Ioannidis JPA, Lau J. State of the evidence (current status and prospect of meta-analysis in infectious diseases). Clin Infect Dis. 1999;29:1178–1185

PII: S0895-4356(02)00393-1

Journal of Clinical Epidemiology
Volume 55, Issue 6 , Pages 619-626 , June 2002

Article Tools